158 related articles for article (PubMed ID: 34304770)
1. Update on Pediatric and Young Adult Mature Lymphomas.
Mason EF; Kovach AE
Clin Lab Med; 2021 Sep; 41(3):359-387. PubMed ID: 34304770
[TBL] [Abstract][Full Text] [Related]
2. Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom.
Singh A; Obiorah IE
Semin Diagn Pathol; 2023 Nov; 40(6):392-400. PubMed ID: 37400280
[TBL] [Abstract][Full Text] [Related]
3. Mature T-cell and NK-cell lymphomas in the pediatric age group.
Jaffe ES
Am J Clin Pathol; 2004 Dec; 122 Suppl():S110-21. PubMed ID: 15690647
[TBL] [Abstract][Full Text] [Related]
4. [Lymphomas in children and adolescents].
Klapper W
Pathologie (Heidelb); 2023 Nov; 44(6):338-347. PubMed ID: 37608069
[TBL] [Abstract][Full Text] [Related]
5. [Pediatric non-Hodgkin lymphomas].
Brousse N; Vasiliu V; Michon J; Canioni D
Ann Pathol; 2004 Dec; 24(6):574-86. PubMed ID: 15785404
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
9. [The many faces of anaplastic large cell lymphoma].
Foss HD; Marafioti T; Stein H
Pathologe; 2000 Mar; 21(2):124-36. PubMed ID: 10840818
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Davies K; Barth M; Armenian S; Audino AN; Barnette P; Cuglievan B; Ding H; Ford JB; Galardy PJ; Gardner R; Hanna R; Hayashi R; Kovach AE; Machnitz AJ; Maloney KW; Marks L; Page K; Reilly AF; Weinstein JL; Xavier AC; McMillian NR; Freedman-Cass DA
J Natl Compr Canc Netw; 2020 Aug; 18(8):1105-1123. PubMed ID: 32755986
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.
Sung CO; Ko YH; Park S; Kim K; Kim W
J Korean Med Sci; 2005 Dec; 20(6):952-6. PubMed ID: 16361803
[TBL] [Abstract][Full Text] [Related]
12. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
14. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
Heerema NA; Bernheim A; Lim MS; Look AT; Pasqualucci L; Raetz E; Sanger WG; Cairo MS
Pediatr Blood Cancer; 2005 Oct; 45(5):616-22. PubMed ID: 16127683
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
16. Pediatric lymphomas in Brazil.
Gualco G; Klumb CE; Barber GN; Weiss LM; Bacchi CE
Clinics (Sao Paulo); 2010; 65(12):1267-77. PubMed ID: 21340214
[TBL] [Abstract][Full Text] [Related]
17. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.
Wright D; McKeever P; Carter R
J Clin Pathol; 1997 Feb; 50(2):128-34. PubMed ID: 9155693
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.
Cho J; Yoon SE; Kim SJ; Ko YH; Kim WS
BMC Cancer; 2021 Aug; 21(1):972. PubMed ID: 34461835
[TBL] [Abstract][Full Text] [Related]
19. Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.
Deffenbacher KE; Iqbal J; Sanger W; Shen Y; Lachel C; Liu Z; Liu Y; Lim MS; Perkins SL; Fu K; Smith L; Lynch J; Staudt LM; Rimsza LM; Jaffe E; Rosenwald A; Ott GK; Delabie J; Campo E; Gascoyne RD; Cairo MS; Weisenburger DD; Greiner TC; Gross TG; Chan WC
Blood; 2012 Apr; 119(16):3757-66. PubMed ID: 22374697
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
